Costs of a clinical pathway with point-of-care testing during influenza epidemic in a Dutch hospital
- PMID: 33047471
- PMCID: PMC7902253
- DOI: 10.1111/irv.12808
Costs of a clinical pathway with point-of-care testing during influenza epidemic in a Dutch hospital
Abstract
Our study aim was to determine how a new clinical pathway, including PCR-based influenza point-of-care test (POCT), influences the hospitalisation costs of patients suspected of influenza presenting at the emergency department of a Dutch hospital during two consecutive influenza epidemics (2016-2017 and 2017-2018). Compared to mean costs per patient of €3661 in 2016-2017, the implementation of this new clinical pathway with influenza POCT in 2017 was associated with mean costs per influenza-positive patient of €2495 in 2017-2018 (P = .3). Our study suggests favourable economic results regarding a new clinical pathway with influenza POCT, reflecting a more efficient care of patients suspected of influenza presenting at the emergency department.
Keywords: clinical pathway; hospitalisation costs; influenza; point-of-care testing.
© 2020 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.
Conflict of interest statement
None declared.
References
-
- Centers·for·Disease·Control·and·Prevention . Prevention Strategies for Seasonal Influenza in Healthcare Settings ‐ guidelines and recommendations. 2017 [cited 15‐3‐2019]. https://www.cdc.gov/flu/professionals/infectioncontrol/healthcaresetting.... Accessed March 15, 2019.
-
- Gibson J, Schechter‐Perkins EM, Mitchell P, et al. Multi‐center evaluation of the cobas((R)) Liat((R)) Influenza A/B & RSV assay for rapid point of care diagnosis. J Clin Virol. 2017;95:5‐9. - PubMed
-
- Lankelma JM, Hermans MHA, Hazenberg E, et al. Implementation of point‐of‐care testing and a temporary influenza ward in a Dutch hospital. Neth J Med. 2019;77(3):109‐115. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical